Call Options

18 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$7.52 - $14.69 $250,416 - $489,177
33,300 Added 85.38%
72,300 $1.01 Million
Q2 2024

Aug 15, 2024

SELL
$5.67 - $8.06 $5,670 - $8,060
-1,000 Reduced 2.5%
39,000 $282,000
Q1 2024

May 07, 2024

BUY
$6.63 - $10.69 $265,200 - $427,600
40,000 New
40,000 $322,000
Q3 2022

Nov 14, 2022

BUY
$8.14 - $12.25 $123,728 - $186,200
15,200 Added 127.73%
27,100 $323,000
Q2 2022

Aug 15, 2022

SELL
$6.99 - $10.0 $234,165 - $335,000
-33,500 Reduced 73.79%
11,900 $97,000
Q1 2022

May 16, 2022

BUY
$7.26 - $10.7 $249,018 - $367,010
34,300 Added 309.01%
45,400 $360,000
Q4 2021

Feb 14, 2022

SELL
$8.8 - $16.0 $278,960 - $507,200
-31,700 Reduced 74.07%
11,100 $104,000
Q4 2020

Feb 16, 2021

BUY
$11.5 - $17.96 $251,850 - $393,324
21,900 Added 104.78%
42,800 $766,000
Q3 2020

Nov 16, 2020

SELL
$10.62 - $13.12 $3.09 Million - $3.81 Million
-290,700 Reduced 93.29%
20,900 $243,000
Q4 2019

Feb 14, 2020

BUY
$11.18 - $18.6 $699,868 - $1.16 Million
62,600 Added 25.14%
311,600 $5.58 Million
Q3 2019

Nov 14, 2019

BUY
$12.09 - $20.46 $3.01 Million - $5.09 Million
249,000 New
249,000 $3.11 Million
Q2 2019

Aug 14, 2019

SELL
$18.5 - $25.47 $619,750 - $853,245
-33,500 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$14.62 - $22.13 $826,030 - $1.25 Million
-56,500 Reduced 62.78%
33,500 $706,000
Q4 2018

Feb 14, 2019

SELL
$17.09 - $38.25 $266,604 - $596,700
-15,600 Reduced 14.77%
90,000 $1.84 Million
Q3 2018

Nov 14, 2018

BUY
$34.05 - $55.9 $2.65 Million - $4.35 Million
77,800 Added 279.86%
105,600 $3.89 Million
Q2 2018

Aug 14, 2018

BUY
$36.15 - $52.5 $93,990 - $136,500
2,600 Added 10.32%
27,800 $1.4 Million
Q1 2018

May 15, 2018

SELL
$24.4 - $40.25 $1.89 Million - $3.12 Million
-77,500 Reduced 75.46%
25,200 $920,000
Q4 2017

Feb 14, 2018

BUY
$18.5 - $28.6 $1.9 Million - $2.94 Million
102,700
102,700 $2.91 Million

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $534M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.